Endometriosis: Why It Can Hide for Years and How New Tests Might Shine a Light

When Zoë Armstrong finally saw the word "endometriosis" on an ultrasound report, she burst into tears and called her mother. "I wasn’t crazy," she said, "I finally had proof of what my body was telling me all those years ago."

Zoë’s story isn’t unique. According to the American College of Obstetricians & Gynecologists, many people wait a decade—or even longer—after the first painful clues appear before receiving a formal diagnosis. Roughly one in ten women worldwide wrestle with this chronic, inflammatory condition that causes tissue similar to the uterine lining to grow where it doesn’t belong.

The symptoms are as varied as the locations the tissue can settle. Common complaints include severe menstrual cramps, pain during sex, bowel‑movement discomfort, bloating, relentless fatigue and, in some cases, infertility. In rare instances the tissue migrates outside the pelvis, adding to the diagnostic puzzle.

Dr. Drorit Or of Mount Sinai West describes the agony vividly: "It can be the kind of pain that forces you to miss school or work, or keeps you bedridden for days." For Zoë, the pain began at age 11 with stabbing sensations on her left side that sent her to the school nurse over and over. As an adult she dealt with nausea, heavy periods, acne, and rupturing ovarian cysts. After marriage she likened the pain to “a tiny fencer stabbing me nonstop for hours.”

Why does it take so long to pin down? A big part is the cultural tendency to accept menstrual pain as normal. Many providers also lack specialized training in endometriosis, and the condition’s signs overlap with other disorders such as irritable bowel syndrome or pelvic inflammatory disease. Dr. Megan Billow of the Cleveland Clinic notes that without awareness, the warning signs can be dismissed.

One practical tip for anyone suspecting endometriosis is to keep a pain diary—note the date, time, location and intensity of each episode. Armed with that record, patients can ask their doctors directly, "Do you think this could be endometriosis?" It transforms a vague complaint into concrete data that clinicians can act on.

Hope may be arriving from across the Atlantic. In the United Kingdom, two novel, non‑invasive tests are currently being trialed in primary‑care settings. The first, EndoSure, measures electrical signals from the gut using sensor pads placed on the abdomen; results are available in about thirty minutes. The second, Endotest, analyzes a saliva sample for micro‑RNAs linked to the disease, delivering answers in two to three weeks.

Both tests have earned provisional endorsement from a UK health advisory body, which plans to use them for three years while gathering more evidence on accuracy and cost‑effectiveness. The goal? Cut the diagnostic lag that leaves so many people suffering in silence.

U.S. companies are watching closely. Maryland‑based EndoSure is preparing an FDA submission, hoping the test can become a useful adjunct for American doctors. Meanwhile, French firm Ziwig is navigating a pathway that lets its Endotest reach U.S. labs without full FDA clearance, positioning it as a first‑step tool that would still be followed by imaging if needed.

American physicians agree that these assays won’t replace the gold‑standard laparoscopy or imaging studies, but they could flag the disease earlier, prompting quicker referrals to specialists. As Dr. Andrew Spiers of Ziwig says, “It’s not the only tool, but it’s a starting point.”

For now, the take‑home message is simple: trust your body, document the pain, and advocate for yourself. The more information you bring to the appointment, the better the chance of ending years of uncertainty.